MTND4P10: A Potential Drug Target and Biomarker (G100873256)

Target Name: MTND4P10

NCBI ID: G100873256

MTND4P10

Other Name(s): MT-ND4 pseudogene 10 | Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 10

MTND4P10: A Potential Drug Target and Biomarker

Methamphetamine (MT) is a highly addictive and illegal drug that has a significant impact on public health and well-being. It is a powerful central nervous system stimulant that can produce feelings of euphoria and increased energy, but it can also lead to serious health consequences, such as cardiovascular problems, addiction, and social problems. The search for new treatments and drug targets for MT has led to the identification of a potential drug target and biomarker, MTND4P10.

MTND4P10 is a protein that is expressed in the brain and is involved in the production of dopamine, which is a neurotransmitter that plays a crucial role in mood, emotion, and motivation. MTND4P10 has been shown to be involved in the development of symptoms of depression and anxiety, as well as the progression of addiction.

One of the key challenges in the search for drug targets is the development of resistance to drugs, which can make treatment more difficult. To address this challenge, researchers have been focusing on identifying proteins that are involved in drug resistance and have found that MTND4P10 is a promising target for drug development.

In addition to its potential as a drug target, MTND4P10 has also been identified as a potential biomarker for drug addiction. The use of antibodies to measure the level of MTND4P10 in the brain can help to determine if a person is currently experiencing addiction. This could be a valuable tool for the development of early interventions and treatments for addiction.

The identification of MTND4P10 as a potential drug target and biomarker is still in the early stages of research, but it has the potential to lead to new treatments and therapies for MT. As the field continues to evolve, it is clear that MTND4P10 is an important target for drug development and could be a valuable tool in the fight against addiction and other serious health consequences associated with MT.

Protein Name: MT-ND4 Pseudogene 10

The "MTND4P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND4P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets